Drug development is an expensive, lengthy, and high-risk business taking 1015 years and is associated with a high attrition rate. Approximately only 1 in 10 …
Global CRO builds technology foundation to drive scalability, efficiency, and compliance PLEASANTON, CA — Sept. 16, 2021 — Veeva Systems (NYSE: VEEV) today announced that Emmes is standardizing …
Naturally, safety event reporting and pharmacovigilance (PV) should be subject to detailed regulatory scrutiny as evidenced by the Food and Drug Administration (FDA) overseeing the …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
